Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Thomas Jefferson University
City of Hope Medical Center